FierceBiotech 2026-02-04 Lilly drops 3 pipeline drugs, including gene therapy, from $1B Prevail buyout
FierceBiotech 2026-02-04 Hims & Hers to sell Grail’s Galleri multi-cancer blood test via its digital health platform
FierceBiotech 2026-02-04 NHS 'FIT' bowel cancer test reduced unnecessary referrals as cancer numbers remain stable
FierceBiotech 2026-02-04 Novo's CEO 'wishes Pfizer luck' with Metsera drug, but still seeks own monthly GLP-1
FierceBiotech 2026-02-04 Amgen advances toward lupus redemption while gastric cancer candidate struggles
FierceBiotech 2026-02-04 NIH turmoil takes center stage as director acknowledges no vaccine-autism link
FierceBiotech 2026-02-03 Pfizer CEO says pipeline pruning is mostly finished after 6 more early-stage culls, $4.4B in impairment charges
FierceBiotech 2026-02-03 Fledgling biotech Exxel plans $13M IPO to succeed where other FAAH inhibitors have failed
FierceBiotech 2026-02-03 FDA signals tailored approach to ‘carefully shepherd’ CAR-T therapy for autoimmune diseases
FierceBiotech 2026-02-03 Pfizer's $10B monthly GLP-1 bet generates competitive weight loss in phase 2b
FierceBiotech 2026-02-03 NMD flunks rare disease trial but flexes secondary data to accelerate program